임상시험 트래커

추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov

24건 표시

1/2상모집 중· Antineutrophil Cytoplasmic Antibody-associated Vasculitis
CC-97540 in Patients With Antineutrophil Cytoplasmic Antibody-associated Vasculitis
협력: BMS
상세 →NCT07388277
1/2상모집 중· SCHIZOPHRENIA 1 (Disorder)
A PET/MRI Study of Cobenfy on Dopamine Transmission in Schizophrenia
협력: BMS
상세 →NCT07423546
1/2상모집 중· Diffuse Midline Glioma
PEP-CMV + Nivolumab for Newly Diagnosed Diffuse Midline Glioma/High-grade Glioma and Recurrent Diffuse Midline Glioma/High-grade Glioma, Medulloblastoma, and Ependymoma
협력: BMS
상세 →NCT06639607
1/2상모집 중· Advanced Renal Cell Carcinoma (RCC)
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Ipilimumab or Cabozantinib in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
리드: BMS · 협력: 바이오엔테크
상세 →NCT07293351
1/2상모집 중· Hepatocellular Carcinoma (HCC)
A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)
리드: BMS · 협력: 바이오엔테크
상세 →NCT07291076
1/2상모집 중· Relapsed/Refractory Small Cell Lung Cancer
A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer
리드: BMS
상세 →NCT07325136
1/2상모집 중· Metastatic Triple-negative Breast Cancer
Saci Nivo Rela for TNBC
협력: BMS
상세 →NCT06963905
1/2상모집 중· Advanced Solid Malignancies
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
리드: BMS
상세 →NCT07223047
1/2상모집 중· Solid Tumours
A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors
리드: BMS
상세 →NCT07160725
1/2상모집 중· Peripheral T Cells Lymphoma (PTCL)
A Platform Trial Evaluating New Drugs or Combination in R/R Peripheral T-cell Lymphomas
협력: 애브비, BMS
상세 →NCT07018752
1/2상모집 중· Advanced Solid Tumors
A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors
리드: BMS
상세 →NCT06697197
1/2상모집 중· Advanced Solid Tumors
A Study of BMS-986490 With or Without Bevacizumab in Advanced Solid Tumors
리드: BMS
상세 →NCT06730750
1/2상모집 중· Lung Cancer
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
리드: BMS
상세 →NCT06618287
1/2상모집 중· Myeloma
Elotuzumab + Iberdomide + Dexamethasone Post Ide-Cel in RRMM
협력: BMS
상세 →NCT06518551
1/2상모집 중· Anemia, Sickle Cell
A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
리드: BMS
상세 →NCT06481306
1/2상모집 중· Childhood Cancer
Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer
협력: BMS
상세 →NCT06208657
1/2상모집 중· Relapsed/Refractory Non-Hodgkin Lymphoma
A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas
리드: BMS
상세 →NCT06090539
1/2상모집 중· Multiple Myeloma
A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma
리드: BMS
상세 →NCT05372354
1/2상모집 중· Cervical Cancer
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
리드: BMS
상세 →NCT04895709
1/2상모집 중· Advanced Cancer
A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of TST001 in Advanced or Metastatic Solid Tumors
협력: BMS
상세 →NCT04495296
1/2상모집 중· Urinary Bladder Cancer
A Study of Mitomycin-c/ Capecitabine ChemoRadiotherapy Combined With Nivolumab Monotherapy or Ipilumimab and Nivolumab, as Bladder Sparing Curative Treatment for Muscle Invasive Bladder Cancer: the CRIMI Study
협력: BMS
상세 →NCT03844256
1/2상모집 중· Hodgkin Lymphoma
Nivolumab With Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma
협력: BMS
상세 →NCT03681561
1/2상모집 중· Sarcoma
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
협력: BMS
상세 →NCT03465592
1/2상모집 중· Multiple Myeloma
Selinexor and Backbone Treatments of Multiple Myeloma Patients
협력: BMS
상세 →NCT02343042

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.